Reviewing Integer Holdings (ITGR) and Globus Medical (GMED)
Integer Holdings (NASDAQ: ITGR) and Globus Medical (NYSE:GMED) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitabiliy, dividends, earnings, institutional ownership and risk.
Volatility & Risk
Integer Holdings has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, Globus Medical has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.
Valuation and Earnings
This table compares Integer Holdings and Globus Medical’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Integer Holdings||$1.41 billion||1.03||$275.03 million||N/A||N/A|
|Globus Medical||$595.44 million||3.57||$206.08 million||$1.11||26.52|
Integer Holdings has higher revenue and earnings than Globus Medical.
This is a breakdown of current ratings for Integer Holdings and Globus Medical, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Integer Holdings presently has a consensus target price of $35.00, indicating a potential downside of 24.65%. Globus Medical has a consensus target price of $29.50, indicating a potential upside of 0.20%. Given Globus Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Globus Medical is more favorable than Integer Holdings.
This table compares Integer Holdings and Globus Medical’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional and Insider Ownership
69.5% of Globus Medical shares are owned by institutional investors. 28.2% of Globus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Globus Medical beats Integer Holdings on 9 of the 13 factors compared between the two stocks.
Integer Holdings Company Profile
Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical’s products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets. QiG focuses on developing medical device systems for some of healthcare’s challenges and reflects the Company’s strategic evolution of its product offerings in order to raise the growth and profitability profile of the Company. QiG utilizes a diversified portfolio approach with three investment modes: new medical device systems commercialization, collaborative programs with OEM customers and strategic equity positions in emerging healthcare companies.
Globus Medical Company Profile
Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company’s products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.
Receive News & Ratings for Integer Holdings Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer Holdings Co. and related companies with MarketBeat.com's FREE daily email newsletter.